Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.899 USD | -14.38% | -24.69% | +64.31% |
May. 14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.31% | 38.75M | |
+53.16% | 63.85B | |
-2.35% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.45% | 26.52B | |
-21.41% | 18.69B | |
+2.75% | 12.73B | |
+22.24% | 12.11B | |
+27.75% | 12.07B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- HC Wainwright Starts Xilio Therapeutics at Buy with $36 Price Target